Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CoDa Therapeutics Closes B Round with $40 Million from Rusnano/ Domain-Led Syndicate

Jul 24 2012

• By Wendy Diller

Related Content

To Russia, With Love: Selecta, BIND To Create Subsidiaries In Financing Deals With Rusnano

Oct 27 2011

Related Companies

CoDa Therapeutics Inc.

Selecta Biosciences, Inc.

BIND Therapeutics, Inc.

UCB S.A.

Additional Topics

Deals Emerging Markets Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window